Freely Filtered 030: DAPA-CKD
Freely Filtered, a NephJC Podcast - Un pódcast de NephJC Team
The DAPA program busted SGLT2i out of the diabetes paradigm by showing that dapagliflozen improved heart failure and CKD outcomes in a patients with or without diabetes.
